Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Current Assets (2016 - 2025)

Neuroone Medical Technologies' Current Assets history spans 14 years, with the latest figure at $8.1 million for Q4 2025.

  • For Q4 2025, Current Assets rose 41.24% year-over-year to $8.1 million; the TTM value through Dec 2025 reached $8.1 million, up 41.24%, while the annual FY2025 figure was $10.2 million, 120.83% up from the prior year.
  • Current Assets reached $8.1 million in Q4 2025 per NMTC's latest filing, down from $10.2 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $16.6 million in Q4 2021 to a low of $3.8 million in Q1 2025.
  • Average Current Assets over 5 years is $8.3 million, with a median of $7.7 million recorded in 2023.
  • Peak YoY movement for Current Assets: tumbled 55.36% in 2023, then soared 148.95% in 2025.
  • A 5-year view of Current Assets shows it stood at $16.6 million in 2021, then plummeted by 45.9% to $9.0 million in 2022, then crashed by 43.2% to $5.1 million in 2023, then increased by 12.15% to $5.7 million in 2024, then soared by 41.24% to $8.1 million in 2025.
  • Per Business Quant, the three most recent readings for NMTC's Current Assets are $8.1 million (Q4 2025), $10.2 million (Q3 2025), and $10.2 million (Q2 2025).